CorMedix Therapeutics Announces Share Repurchase Program GlobeNewswire February 02, 2026 BERKELEY HEIGHTS, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) — CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced its Board of Directors has approved a share repurchase program, which authorizes the Company to […]

Patria Announces Date Change for its Fourth Quarter & Full Year 2025 Investor Call GlobeNewswire February 02, 2026 GRAND CAYMAN, Cayman Islands, Feb. 02, 2026 (GLOBE NEWSWIRE) — Patria Investments Limited (“Patria”) (NASDAQ: PAX) announced today that it has changed the date it will release financial results for the fourth quarter and full year 2025

Trump Media Reiterates Record Date for Digital Token Initiative DJT Shareholders as of Feb. 2 Eligible to Participate GlobeNewswire February 02, 2026 SARASOTA, Fla., Feb. 02, 2026 (GLOBE NEWSWIRE) — Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: DJT) (“Trump Media” or the “Company”), operator of the social media platform Truth Social, the streaming

Falco Announces Extension of Certain Deadlines Under the Silver Stream Transaction GlobeNewswire February 02, 2026 MONTRÉAL, Feb. 02, 2026 (GLOBE NEWSWIRE) — Falco Resources Ltd. (TSX.V: FPC) (“Falco” or the “Corporation“) is pleased to announce that the Corporation and OR Royalties Inc. (“OR“) have entered into an amendment to the silver purchase agreement dated February

ScanTech AI Systems Launches Collaborative Pilot Program with the City of Atlanta, in Preparation for 2026 FIFA Football World Cup Events GlobeNewswire February 02, 2026 Atlanta, GA, Feb. 02, 2026 (GLOBE NEWSWIRE) — ScanTech AI Systems Inc. (the “Company” or “ScanTech AI”) (Nasdaq: STAI), a developer of advanced AI-powered security screening and imaging systems, today

IperionX – 2026 Letter to Shareholders GlobeNewswire February 02, 2026 SOUTH BOSTON, Va., Feb. 02, 2026 (GLOBE NEWSWIRE) — IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) IperionX has released its 2026 letter from CEO Taso Arima to shareholders and other valued stakeholders, outlining plans to grow the U.S.'s leading domestic titanium manufacturing platform, essential to

Dogwood Therapeutics Announces 50% Enrollment in Ongoing Halneuron(R) Phase 2b Trial, Top Line Results Anticipated in Q3 2026 GlobeNewswire February 02, 2026 – Low early termination rate (4.3%) among the first 116 patients completing the study suggests Halneuron(R) treatment to be well tolerated – ATLANTA, Feb. 02, 2026 (GLOBE NEWSWIRE) — Dogwood Therapeutics, Inc. (Nasdaq:

Oragenics to Participate in SCOPE Summit 2026 Focused on Advancing Clinical Research and Patient Care GlobeNewswire February 02, 2026 Management to Engage with Global Clinical Research Leaders Ahead of Phase 2a Trial of Concussion Treatment Sarasota, Fla., Feb. 02, 2026 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN) (“the “Company”), a clinical-stage biotechnology company focused

NewtekOne, Inc. Retires $95 Million of Senior Unsecured Notes GlobeNewswire February 02, 2026 BOCA RATON, Fla., Feb. 02, 2026 (GLOBE NEWSWIRE) — NewtekOne, Inc. (the “Company”) (NASDAQ: NEWT) retired $95 million of fixed rate senior notes that matured on February 1, 2026. The 5-year notes, which were publicly traded under the ticker symbol “NEWTZ”, were

Draganfly Selected to Provide Draganfly Flex FPV Drones and Training to U.S. Air Force Special Operations Command Units in Partnership with DelMar Aerospace GlobeNewswire February 02, 2026 Tampa, Fla., Feb. 02, 2026 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning developer of drone solutions, software, and